How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety
Starts On:
Fri, 2/11/22: 12:00 AM EST
Ends On:
Tue, 12/31/24: 11:45 PM EST
Type:
Enduring Material
Credits:
1
Description:
This webinar described the role of the FDA Division of Medication Error Prevention and Analysis (DMEPA) in preventing and addressing medication errors through pre-market and post-market activities. DMEPA collaborates with the nonprofit Institute for Safe Medication Practices (ISMP), to share information from the ISMP National Medication Errors Reporting Program in a way that benefits overall drug safety. Actions taken to address recent medication error reports were explored, and the role of health care practitioners in identifying, preventing, and mitigating medication errors were discussed.
Objectives:
- Explain FDA’s role in pre-marketing and post-marketing activities to prevent and address medication errors.
- Summarize how HCPs can help identify, prevent, and mitigate medication errors through adverse event reporting.
- Describe how FDA, ISMP utilize medication error reports to address reported safety issues.
- Outline strategies aimed to increase the safe use of drug products by minimizing user error related to the design, naming, labeling, and/or packaging of drug products.
- Review examples of actions taken to address recently reported medication error reports.
Additional Information:
Review the Activity Announcement for additional details: Announcement Form
Additional Resources: Slides
Additional Resources: Slides
- This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.
- This system is provided for Government-authorized use only.
- Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.
- Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.
- By using this system, you understand and consent to the following:
- The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.
- Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.
